Cell type-specific expression and negative regulation by retinoic acid of the human N-myc promoter in neuroblastoma cells

Oncogene. 1992 Apr;7(4):711-7.

Abstract

Expression of the N-myc oncogene is an important determinant of tumor behavior in human neuroblastoma. To study the regulation of N-myc, we have subcloned fragments of the 5' flanking region of the human N-myc gene upstream of the chloramphenicol acetyl transferase (CAT) reporter gene, and assayed for promoter activity in transient transfections into neuroblastoma and other cell lines. Upstream sequences were found to possess promoter activity to within 121 bp of the major cap site (-121). Negative regulatory elements were identified in regions approximately 2 kb and 500 bp upstream from the major cap site, as well as 150-1000 bp downstream. Promoter constructs containing downstream elements from bp +150 to +1000 were active in N-myc-expressing neuroblastoma cell lines, but not in non-expressing Epstein-Barr virus (EBV)-transformed 729-6 B-cell or HeLa cell lines, while those lacking this element were active in all cell types tested. All tested constructs retaining promoter activity showed decreased activity in parallel with the down-regulation of endogenous N-myc in response to treatment of transfected cells with retinoic acid. These studies suggest that N-myc regulation may be controlled at different levels, and provide a basis for further characterization of N-myc regulation in neuroblastoma.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • DNA Mutational Analysis
  • Gene Expression Regulation / drug effects*
  • Genes, myc*
  • Humans
  • In Vitro Techniques
  • Neuroblastoma / genetics
  • Promoter Regions, Genetic*
  • Proto-Oncogene Proteins c-myc / genetics*
  • Restriction Mapping
  • Tretinoin / pharmacology*
  • Tumor Cells, Cultured

Substances

  • Proto-Oncogene Proteins c-myc
  • Tretinoin